Beijing Tiantan Biological Products Corp. Ltd. (600161) Stock Analysis

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of 14.10% and Operating profit at 18.18% over the last 5 years

INTEREST(9M) At CNY 3.71 MM has Grown at 45.41%
OPERATING CASH FLOW(Y) Lowest at CNY -688.6 MM
NET PROFIT(HY) At CNY 539.42 MM has Grown at -25.71%

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 37,728 Million (Large Cap)

P/E

19.00

Industry P/E

Dividend Yield

0.44%

Debt Equity

-0.16

Return on Equity

17.22%

Price to Book

3.26

Revenue and Profits:

Net Sales:

1,774 Million

(Quarterly Results - Jun 2025)

Net Profit:

529 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-14.27%

6 Months

-11.87%

1 Year

-20.49%

2 Years

-35.57%

3 Years

-8.52%

4 Years

-42.29%

5 Years

-41.64%

Beijing Tiantan Biological Products Corp. Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

14.10%

EBIT Growth (5y)

18.18%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.20

Sales to Capital Employed (avg)

0.52

Tax Ratio

17.23%

Dividend Payout Ratio

12.76%

Pledged Shares

Institutional Holding

ROCE (avg)

28.16%

ROE (avg)

16.39%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.26

EV to EBIT

15.74

EV to EBITDA

13.31

EV to Capital Employed

3.69

EV to Sales

5.72

PEG Ratio

Dividend Yield

0.44%

ROCE (Latest)

23.46%

ROE (Latest)

17.22%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 35.99% vs -32.73% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 56.69% vs -50.75% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,774.00",
          "val2": "1,304.50",
          "chgp": "35.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "719.50",
          "val2": "500.40",
          "chgp": "43.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "2.40",
          "chgp": "-20.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "528.50",
          "val2": "337.30",
          "chgp": "56.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "341.50%",
          "val2": "296.50%",
          "chgp": "4.50%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.35% vs 21.71% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 39.93% vs 25.30% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,970.90",
          "val2": "5,131.80",
          "chgp": "16.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,825.70",
          "val2": "1,981.80",
          "chgp": "42.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.90",
          "val2": "6.00",
          "chgp": "31.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-21.10",
          "val2": "0.70",
          "chgp": "-3,114.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,112.30",
          "val2": "1,509.50",
          "chgp": "39.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "413.20%",
          "val2": "330.70%",
          "chgp": "8.25%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

1,774.00

1,304.50

35.99%

Operating Profit (PBDIT) excl Other Income

719.50

500.40

43.78%

Interest

1.90

2.40

-20.83%

Exceptional Items

0.00

Consolidate Net Profit

528.50

337.30

56.69%

Operating Profit Margin (Excl OI)

341.50%

296.50%

4.50%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 35.99% vs -32.73% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 56.69% vs -50.75% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

5,970.90

5,131.80

16.35%

Operating Profit (PBDIT) excl Other Income

2,825.70

1,981.80

42.58%

Interest

7.90

6.00

31.67%

Exceptional Items

-21.10

0.70

-3,114.29%

Consolidate Net Profit

2,112.30

1,509.50

39.93%

Operating Profit Margin (Excl OI)

413.20%

330.70%

8.25%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 16.35% vs 21.71% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 39.93% vs 25.30% in Dec 2023

All Annual Results

Company CV

About Beijing Tiantan Biological Products Corp. Ltd.

Beijing Tiantan Biological Products Corp. Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available